Category
pharmacokinetics
How peptides move through the body: absorption, half-life, delivery routes, and why most of them cannot simply be swallowed.
pharmacokinetics
Oral peptide bioavailability: what research shows
Ian Gauntt, RN BSN · Sep 17, 2026 · 14 min
Oral peptide bioavailability is notoriously low. Recent preclinical and formulation research explains why—and what scientists are testing to fix it.
pharmacokinetics
Bioavailability Barriers: Why Peptides Fail
Ian Gauntt, RN BSN · Sep 10, 2026 · 14 min
Bioavailability barriers stop most therapeutic peptides from reaching targets. Preclinical research reveals why—and what scientists are testing.
pharmacokinetics
BPC-157 Pharmacokinetics: What Research Shows
Ian Gauntt, RN BSN · Sep 3, 2026 · 13 min
BPC-157 pharmacokinetics pose real formulation challenges. Here is what preclinical and early translational research shows about this investigational peptide.
pharmacokinetics
Antimicrobial Peptides: How Delivery Shapes Efficacy
Ian Gauntt, RN BSN · Aug 27, 2026 · 16 min
Antimicrobial peptides show promise against drug-resistant bacteria, but delivery barriers limit their reach. Here's what preclinical research reveals.
pharmacokinetics
Peptide Delivery: How Stimuli-Responsive Systems Work
Ian Gauntt, RN BSN · Aug 20, 2026 · 13 min
Explore how stimuli-responsive peptide delivery systems control release timing, reduce burst effects, and improve pharmacokinetics in preclinical research.
pharmacokinetics
Burst Release: Why Peptide Timing Matters
Ian Gauntt, RN BSN · Aug 13, 2026 · 16 min
Burst release can undermine peptide therapies. Learn what preclinical research reveals about controlling drug timing in modern delivery systems.
pharmacokinetics
Peptide Delivery: How Nanotech Solves It
Ian Gauntt, RN BSN · Aug 6, 2026 · 14 min
Peptide delivery is transformed by nanoarchitectures and stimuli-responsive systems. Explore what preclinical research reveals about bioavailability challenges.
pharmacokinetics
Peptide Pharmacokinetics: Why Delivery Matters
Ian Gauntt, RN BSN · Jul 30, 2026 · 14 min
Peptide pharmacokinetics shape how well these molecules reach their targets. Learn what preclinical research reveals about modern delivery strategies.
pharmacokinetics
Peptide Pharmacokinetics: Absorption & Half-Life
Ian Gauntt, RN BSN · Jul 13, 2026 · 2 min
Why oral bioavailability is often under 1%, why parenteral is the default, and how half-life engineering changes the dosing equation. The PK essentials.